Life sciences companies remain a prime focus of Foreign Corrupt Practices Act (FCPA) compliance investigations because of their operational platforms and the significant government regulation across the industry. In 2016, the largest FCPA investigations and settlements involved life sciences companies, adding up to hundreds of millions of dollars in fines and penalties. Additional significant FCPA investigations and settlements in the life sciences industry are expected in 2017.
Register now for this one-hour complimentary webinar with AGG Partners, Sara M. Lord, an award-winning former Federal prosecutor, and Michael E. Burke as they discuss:
- FCPA compliance challenges facing the life sciences industry
- Compliance best practices
- What companies should do when an investigation is opened
- A look ahead to 2017 and beyond
Credits: This webinar is pending CLE credit approval by the State Bar of Georgia.